Ep 16 – Dr. Laura Esserman, Professor of Surgery and Radiology UCSF, Director of the UCSF Breast Care Clinic

Dr. Laura Esserman is a leading figure in the transformation of American medicine. Named one of Time Magazine’s 100 Most Influential People in the World, Laura is dedicated to increasing the speed at which we learn about new cancer drugs and treatments. She discusses her transformation into becoming a more effective version of herself through storytelling and cultivating empathy with opponents.

Join us and learn about:

Adjustments in her behavior that make her extraordinarily effective
The importance of knowing what you want to accomplish over being likable
Realizing to become successful, she needed to get out of her way
The listening and give-and-take skills that enable effectiveness
Allowing the space for people to think differently than yourself
Finding common ground to accomplish shared goals
How fear of criticism can impede problem-solving
Patient-centered care with a ‘no risk, no change’ philosophy
Going to the mat and doing things for others
The principles she lives on
Her lesson with running a mammogram van in San Francisco
How empathy and understanding aid negotiations
Using the press and publicity to make change happen
Why storytelling is paramount for learning
Her goal of bringing personalized medicine to trials and patients
The unique skills she brings to her patients that will surprise you

GUEST BIO

Dr. Laura Esserman is Professor of Surgery and Radiology at the University of California, San Francisco (UCSF) and director of the UCSF Breast Care Clinic. Her work in breast cancer spans the spectrum from basic science to public policy issues, and the impact of both on the delivery of clinical care. Dr. Esserman is recognized as a thought leader in cancer screening and over-diagnosis, as well as innovative clinical trial design. She led the creation of the University of California-wide Athena Breast Health Network, a learning system designed to integrate clinical care and research as it follows 150,000 women from screening through treatment and outcomes. The Athena Network launched the PCORI-funded Wisdom Study, which tests a personalized approach to breast cancer screening in 100,000 women. She is also a leader of the innovative I-SPY TRIAL model, designed to accelerate the identification and approval of effective new agents for women with high-risk breast cancers. In 2020, she got FDA approval for an I-SPY COVID trial, designed to rapidly screen and confirm high-impact treatments to reduce mortality and time on ventilators.

Produced by The MunnAvenuePress.com